NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . August 25th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Heart Failure - Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure

PolyMedix, Inc. - PolyMedix Has Regulatory Clearance to Initiate Phase I Clinical Study of Novel Anticoagulant Antagonist Compound

Breast Cancer - Research on breast cancer reported by A. Fabi et al

Cancer Vaccines - Findings in cancer vaccines reported from R. Ramlau and co-researchers

Colon Cancer - New colon cancer research from T. Gamucci and colleagues discussed

Endometrial Cancer - Research findings from University Hospital update understanding of endometrial cancer

Hepatocellular Cancer - Reports summarize hepatocellular cancer study results from J.M. Llovet and co-researchers

Life Sciences - Study findings from J. Autier et al broaden understanding of life sciences

Lung Cancer - Studies from M. Bigioni et al provide new data on lung cancer

Melanoma - New melanoma study findings have been published by scientists at Melanoma Center

Nasopharyngeal Carcinoma - Reports from University of Hong Kong describe recent advances in nasopharyngeal carcinoma

Non-Small Cell Lung Cancer - Research reports on non-small cell lung cancer from P. Baas and colleagues provide new insights

Prostate Cancer - Reports from K.N. Chi and co-researchers add new data to research in prostate cancer

Reovirus - Data from C.L. White and colleagues advance knowledge in reovirus

Stem Cell Research - Research conducted at J. Holowiecki and co-researchers has updated our knowledge about stem cell research

Thrombocytopenia - Data on thrombocytopenia reported by researchers at University of Colorado

Type 2 Diabetes - Studies from S.L. Schwartz et al add new findings in the area of type 2 diabetes

Cancer Therapy - Studies from Research Center in the area of cancer therapy published

HIV/AIDS Prevention - Studies from London School of Hygiene & Tropical Medicine have provided new data on HIV/AIDS prevention

Monoclonal Antibodies - Research from P.D. Miller and co-authors in the area of monoclonal antibodies published

Pancreatic Cancer Therapy - Study data from University of Texas, M. D. Anderson Cancer Center update knowledge of pancreatic cancer therapy

Prostate Cancer - Research data from University of Maryland, Department of Pharmacology update understanding of prostate cancer

Altus Pharmaceuticals Inc. - Altus Pharmaceuticals Announces Achievement of Primary Endpoint in Phase 3 Efficacy Trial of Trizytek for Cystic Fibrosis Patients with Pancreatic Insufficiency

Anesiva, Inc. - Anesiva Announces Second Quarter 2008 Financial Results and Update

ArQule, Inc. - ArQule Reports Second Quarter 2008 Financial Results

Biotechnology Business - BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results

Breast Cancer - Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer

Cancer - Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist

Cancer Vaccines - MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research

Catalyst Pharmaceutical Partners, Inc. - Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results

Champions Biotechnology, Inc. - Champions Biotechnology, Inc. Retains the Investor Relations Group

Clinical Trial Research - Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis

Clinical Trial Research - Isis Initiates Clinical Trial of CRP Drug

Clinical Trial Research - TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results

Coagulation - Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172

CPEX Pharmaceuticals, Inc. - CPEX Pharmaceuticals Signs Contract Manufacturing Agreement

Drug Development - Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.

Drug Development - NeurogesX Reports Second Quarter 2008 Results

Halozyme Therapeutics, Inc. - Halozyme Therapeutics Reports 2008 Second Quarter Financial Results

Lupus - Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus

Lupus - MedImmune Initiates First Phase 2 Trial in Lupus Patients With its Antibody Targeting Interferon-alpha

Lymphoma - Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab

Myeloma - Three Researchers to Receive Prestigious Awards From the American Society of Hematology

NeoPharm, Inc. - NeoPharm, Inc. Announces Second Quarter 2008 Financial Results

New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College - Results of 9-month phase II study of gammagard intravenous immunoglobulin

Novalar Pharmaceuticals, Inc. - Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse a Local Anesthetic Reversal Agent

Opexa Therapeutics, Inc. - Opexa Therapeutics Completes $3 Million Financing

Post Operative Pain - Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain

Prostate Cancer - Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer

Stromedix, Inc. - Stromedix Receives Orphan Drug Designation for STX-100 in Chronic Allograft Nephropathy

Sucampo Pharmaceuticals, Inc. - Sucampo Pharmaceuticals Reports Financial Results for the Second Quarter of 2008

The Multiple Myeloma Research Consortium - The Multiple Myeloma Research Consortium MMRC Announces Initiation of First Four-Drug Combination Study to Treat Newly Diagnosed Multiple Myeloma Patients

Tikcro Technologies Ltd. - Tikcro Technologies Reports 2008 Second Quarter Results



Return to Top of Page

-----------------------
PR Login